Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children
NCT01754948 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2012-12-21
Summary
Background Ambient airborne particulate material (PM) is defined according the aerodynamic diameter into coarse, fine, and ultrafine or "nano" sized particles ranging between 2.5-10 µm (coarse), \<2.5 µm (fine), and \<0.1 µm (nano(. Many studies have examined particle effect on respiratory health in children, mainly by environmental monitoring of coarse and fine particles. Biological assessment of individual exposure to nano sized particles in correlation to adverse health effect was not previously studied.
Hypothesis individual exposure to nano sized particles in children is associated with reduction in forced expiratory volume at one second.
Conditions
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Principal Investigators
-
Shira Benor, MD · Tel Aviv Medical Center
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Israel
Study Locations
More Related Trials
-
A 24-week rPMS Study in Real-world Setting for Enerzair
NCT05274425 ·Status: RECRUITING
-
Effect of Specific Immunotherapy to Dust Mites in Children With Asthma
NCT00496561 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Mesh Nebulizer and Compressor Nebulizer With Pulmonary Function Test in Pediatric Asthma Attacks
NCT06211998 ·Status: COMPLETED ·Phase: NA
-
Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Biological Therapy.
NCT05792592 ·Status: UNKNOWN
-
Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma
NCT01092403 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
NCT00546143 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma
NCT01448954 ·Status: COMPLETED ·Phase: PHASE2
-
The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
NCT01225549 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
NCT03988790 ·Status: UNKNOWN ·Phase: NA
-
Environmental Intervention to Reduce Allergens in Urban Schools and Childhood Asthma
NCT01913795 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma
NCT01793298 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
NCT00595491 ·Status: RECRUITING ·Phase: PHASE1
-
Mechanisms of Interplay Between Allergy and Viruses in Asthma
NCT01773590 ·Status: COMPLETED ·Phase: NA
-
Role of Eosinophils in the Proliferation of Airway Smooth Muscle (ASM) Cells
NCT01082952 ·Status: COMPLETED
-
Effectiveness of the Aeroneb in Acute Severe Asthma
NCT03029156 ·Status: COMPLETED ·Phase: NA
-
Exhaled Nitric Oxide and Nasal Lavage Fluid
NCT00773578 ·Status: COMPLETED
-
Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma
NCT02773628 ·Status: TERMINATED ·Phase: NA
-
Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic
NCT01179152 ·Status: UNKNOWN ·Phase: NA
-
A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
NCT03100825 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
NCT01479595 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma
NCT02872298 ·Status: TERMINATED ·Phase: NA
-
The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
NCT01741805 ·Status: WITHDRAWN
-
Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma
NCT00550797 ·Status: COMPLETED ·Phase: PHASE2